Health Condition 1: M279- Disease of jaws, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults diagnosed with Temporomandibular Disorders (TMD) based on the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) will be eligible for the study. Participants must have experienced chronic orofacial pain for more than three months and demonstrate willingness to provide informed consent and comply with all study procedures.
Exclusion criteria
Exclusion criteria: Individuals with a history of orofacial surgery or trauma within the past six months, neurological disorders affecting facial muscles, or those currently undergoing orthodontic treatment or using occlusal splint therapy will be excluded. Participants with severe psychiatric illness or those unable to complete study questionnaires, as well as pregnant or lactating women, will also not be eligible for inclusion in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes of this study include changes in pain intensity measured using the Visual Analogue Scale (VAS), changes in oral function assessed through the Jaw Functional Limitation Scale (JFLS), and evaluation of orofacial alignment using clinical assessment and standardized photographs. Additionally, patient-reported satisfaction with facial glow will be measured using a Likert scale.Timepoint: Baseline, Week 3, Week 6 (end of treatment), 1-month follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes include assessment of quality of life using the Oral Health Impact Profile (OHIP-14), evaluation of anxiety and depression levels with the Hospital Anxiety and Depression Scale (HADS), and monitoring of the intervention?s safety profile through systematic reporting of any adverse events.Timepoint: Baseline, Week 3, Week 6 (end of treatment), 1-month follow-up. | — |
Countries
India
Contacts
Lovely Professional University Faculty of Applied Medical Sciences